Two medicines for overactive bladder in women
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether taking two medications together — gabapentin and solifenacin — helps reduce the strong, sudden urge to urinate and urine leaks in women with overactive bladder. It may offer a new treatment option that works better than current ones.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman with frequent, strong urges to urinate (overactive bladder).
- Your symptoms must be severe enough that your doctor has measured them with a standard score (usually more than 5 on a symptom questionnaire).
- You must have both urgent urination and some urine leakage right after the urge.
- You cannot have a current urinary tract infection.
- You cannot have bladder problems caused by nerve damage (neurogenic bladder) or a history of bladder or genital cancer.
- Your main problem cannot be stress incontinence (leaking with cough or laugh).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares electroacupuncture (a type of acupuncture using mild electrical stimulation) with solifenacin, a bladder medication, for women with overactive bladder. It aims to see which treatment works better to reduce bladder urgency and frequent urination.
This study tests medicines to reduce “urgency” urine leakage (when you suddenly feel you must go) and to see whether improving bladder control also helps overall mental and physical health. You may be eligible if you have had these symptoms for at least 3 months and can follow the study plan.
This trial tests a new procedure that uses radiofrequency energy to calm the nerve responsible for overactive bladder in women. It aims to reduce urge-related urine leaks without surgery or medications.
This study compares two medications—tadalafil (a daily pill for blood flow) and solifenacin (a pill that relaxes the bladder)—to see which works better for women with overactive bladder (OAB), which causes sudden, strong urges to urinate. It will help doctors find a treatment that may have fewer side effects.
This trial compares a new treatment (low-intensity shockwave therapy) with a standard medication (solifenacin) to see which works better for women with overactive bladder (OAB). Overactive bladder means you feel a sudden, strong need to urinate, often have to go frequently, or may leak urine. The study aims to find a more effective or better-tolerated option.
This study compares the effectiveness of a combination of medications (solifenacin and mirabegron) versus solifenacin alone with a vaginal estrogen cream for treating women with overactive bladder. It may help those who haven't improved with single medication.
Hear when a new Overactive Bladder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.